-
Loading metrics
Open Access
Peer-reviewed
Research Article
JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE
-
Edaire Cheng ,
* E-mail: edaire.cheng@utsouthwestern.edu
Affiliations Esophageal Diseases Center, Veterans Affairs North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Department of Pediatrics, Children’s Health Children’s Medical Center, Dallas, Texas, United States of America, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Medical Services, Veterans Affairs North Texas Health Care System, Dallas, Texas, United States of America, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯ -
Xi Zhang,
Affiliations Esophageal Diseases Center, Veterans Affairs North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Medical Services, Veterans Affairs North Texas Health Care System, Dallas, Texas, United States of America, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯ -
Kathleen S. Wilson,
Affiliations Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯ -
David H. Wang,
Affiliations Esophageal Diseases Center, Veterans Affairs North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Medical Services, Veterans Affairs North Texas Health Care System, Dallas, Texas, United States of America, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯ -
Jason Y. Park,
Affiliations Esophageal Diseases Center, Veterans Affairs North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Department of Pathology, Children’s Health Children’s Medical Center, Dallas, Texas, United States of America
⨯ -
Xiaofang Huo,
Affiliations Esophageal Diseases Center, Veterans Affairs North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Medical Services, Veterans Affairs North Texas Health Care System, Dallas, Texas, United States of America, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯ -
Chunhua Yu,
Affiliations Esophageal Diseases Center, Veterans Affairs North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Medical Services, Veterans Affairs North Texas Health Care System, Dallas, Texas, United States of America, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯ -
Qiuyang Zhang,
Affiliations Esophageal Diseases Center, Veterans Affairs North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Medical Services, Veterans Affairs North Texas Health Care System, Dallas, Texas, United States of America, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯ -
Stuart J. Spechler,
Affiliations Esophageal Diseases Center, Veterans Affairs North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Medical Services, Veterans Affairs North Texas Health Care System, Dallas, Texas, United States of America, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯ -
Rhonda F. Souza
Affiliations Esophageal Diseases Center, Veterans Affairs North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Medical Services, Veterans Affairs North Texas Health Care System, Dallas, Texas, United States of America, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯
JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE
- Edaire Cheng,
- Xi Zhang,
- Kathleen S. Wilson,
- David H. Wang,
- Jason Y. Park,
- Xiaofang Huo,
- Chunhua Yu,
- Qiuyang Zhang,
- Stuart J. Spechler,
- Rhonda F. Souza
- Published: June 16, 2016
- https://doi.org/10.1371/journal.pone.0157376